U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841535) titled 'Molecular-based Optimization of Pathogen Identification in Sepsis Patients in the Indonesian National Referral Hospital' on Aug. 20.
Brief Summary: This study aims to compare the diagnostic performance of conventional blood culture with two molecular-based diagnostic approaches, Hybrispot DNA Flow and metagenomic next-generation sequencing (mNGS), for the identification of microorganisms in patients with sepsis. The study will evaluate the turnaround time of each diagnostic method and assess their potential impact on the time to definitive antimicrobial therapy and subsequent clinical outcomes.
The study is led by Robert Sinto, an...